1. Home
  2. JCSE vs CANF Comparison

JCSE vs CANF Comparison

Compare JCSE & CANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JE Cleantech Holdings Limited

JCSE

JE Cleantech Holdings Limited

HOLD

Current Price

$0.82

Market Cap

4.8M

ML Signal

HOLD

Logo Can-Fite Biopharma Ltd Sponsored ADR (Israel)

CANF

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

HOLD

Current Price

$4.39

Market Cap

5.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JCSE
CANF
Founded
1999
1994
Country
Singapore
Israel
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8M
5.4M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
JCSE
CANF
Price
$0.82
$4.39
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$9,750.00
AVG Volume (30 Days)
207.6K
72.5K
Earning Date
10-30-2025
03-27-2026
Dividend Yield
10.36%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,804,296.00
$560,000.00
Revenue This Year
N/A
$461.72
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.80
$3.36
52 Week High
$2.50
$46.60

Technical Indicators

Market Signals
Indicator
JCSE
CANF
Relative Strength Index (RSI) 33.60 61.93
Support Level $0.85 $4.02
Resistance Level $1.69 $4.74
Average True Range (ATR) 0.14 0.28
MACD -0.06 -0.12
Stochastic Oscillator 0.00 29.73

Price Performance

Historical Comparison
JCSE
CANF

About JCSE JE Cleantech Holdings Limited

JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The product lives of its cleaning systems and other equipment ranges from two to ten years. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. The company derives the majority of its revenue from the Sales of cleaning systems and other equipment. Geographically, the company derives a majority of its revenue from Singapore, followed by Malaysia.

About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.

Share on Social Networks: